Tag: HTA

Biomarker, Innovation, Research

Study: Some countries take more time for reimbursement decisions on new cancer drugs

October 19, 2018

Via: The Medical News

Some European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs following their approval by the European Medicines Agency (EMA). The average decision time is longer than one […]